- Report
- October 2023
- 150 Pages
Global
From €5661EUR$5,950USD£4,822GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1903EUR$2,000USD£1,621GBP
- Clinical Trials
- April 2024
- 65 Pages
Global
From €1427EUR$1,500USD£1,216GBP
- Clinical Trials
- February 2024
- 60 Pages
Global
From €1189EUR$1,250USD£1,013GBP
- Report
- January 2024
- 143 Pages
Global
From €4044EUR$4,250USD£3,444GBP
- Report
- February 2024
- 181 Pages
Global
From €4662EUR$4,900USD£3,971GBP
- Report
- October 2023
- 190 Pages
Global
From €4662EUR$4,900USD£3,971GBP
- Report
- November 2023
- 115 Pages
United States
From €3568EUR$3,750USD£3,039GBP
- Report
- November 2022
- 230 Pages
Global
From €3568EUR$3,750USD£3,039GBP
- Report
- June 2023
- 115 Pages
United States
From €3568EUR$3,750USD£3,039GBP
- Report
- August 2022
- 110 Pages
Global
From €4519EUR$4,750USD£3,850GBP
- Report
- August 2022
- 118 Pages
Global
From €4281EUR$4,500USD£3,647GBP
- Report
- May 2023
- 157 Pages
Global
From €2379EUR$2,500USD£2,026GBP
- Report
- March 2020
- 90 Pages
Asia Pacific
From €1427EUR$1,500USD£1,216GBP
- Report
- March 2020
- 78 Pages
North America
From €1427EUR$1,500USD£1,216GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$3,941USD£3,086GBP
- Report
- October 2022
- 270 Pages
Global
From €3397EUR$3,570USD£2,893GBP
Topical corticosteroids form an essential class of anti-inflammatory and immunosuppressive drugs widely used in healthcare services for the treatment of a variety of dermatological conditions. They are administered directly onto the skin to relieve inflammation, itching, and irritation caused by conditions such as eczema, psoriasis, allergic reactions, and rashes. These medications vary in potency, ranging from mild to ultra-high, thus allowing practitioners to tailor treatment plans based on the severity of the patient's condition. Within healthcare services, topical corticosteroids are also leveraged in conjunction with other treatments to manage chronic skin diseases effectively. The market for these drugs is characterized by an extensive range of products, including creams, ointments, lotions, gels, and foams, which are often available by prescription but can also include over-the-counter options for milder applications.
Several pharmaceutical companies partake in the production and distribution of topical corticosteroids. Key players typically include large, multinational corporations as well as specialized dermatology companies. Some noteworthy participants in this market include Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi, and Johnson & Johnson. Additionally, a number of generic drug manufacturers contribute to the market, offering more cost-effective therapeutic alternatives. Show Less Read more